MoneyWorks4Me

Venus Remedies - Quaterly Results

13 Aug 2024 Evaluate
The June 2024 quarter revenue stood at Rs. 1058.60 millions, up 7.33% as compared to Rs. 986.30 millions during the corresponding quarter last year.Profit after tax improved marginally to Rs. 44.50  millions for the quarter ended June 2024 from Rs. 43.40 millions of corresponding previous quarter.The company reported a good operating profit of 158.40 millions compared to 155.30 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1058.60 986.30 7.33 1058.60 986.30 7.33 5752.10 5376.60 6.98
Other Income 15.60 20.60 -24.27 15.60 20.60 -24.27 113.20 101.70 11.31
PBIDT 158.40 155.30 2.00 158.40 155.30 2.00 722.00 717.00 0.70
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 158.40 155.30 2.00 158.40 155.30 2.00 722.00 717.00 0.70
Depreciation 57.60 73.20 -21.31 57.60 73.20 -21.31 255.50 313.70 -18.55
PBT 100.80 82.10 22.78 100.80 82.10 22.78 466.50 403.30 15.67
TAX 56.30 38.70 45.48 56.30 38.70 45.48 161.50 113.70 42.04
Deferred Tax 30.90 4.80 543.75 30.90 4.80 543.75 39.30 113.70 -65.44
PAT 44.50 43.40 2.53 44.50 43.40 2.53 305.00 289.60 5.32
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 14.96 15.75 -4.97 14.96 15.75 -4.97 12.55 13.34 -5.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..